Perinatal Psychopharmacology

This book focuses on recent advances in research and practical recommendations regarding the use of psychotropic drugs during pregnancy and lactation, two important social and psychological life events for women. In addition to the social context, includi

  • PDF / 4,606,600 Bytes
  • 367 Pages / 439.42 x 683.15 pts Page_size
  • 94 Downloads / 219 Views

DOWNLOAD

REPORT


123

Perinatal Psychopharmacology

Faruk Uguz  •  Laura Orsolini Editors

Perinatal Psychopharmacology

Editors Faruk Uguz Meram Faculty of Medicine Necmettin Erbakan University Konya Turkey

Laura Orsolini Psychopharmaological, Drug Misuse and Novel Psychoactive Substances Research Unit University of Hertfordshire Hatfield UK

ISBN 978-3-319-92918-7    ISBN 978-3-319-92919-4 (eBook) https://doi.org/10.1007/978-3-319-92919-4 Library of Congress Control Number: 2018968106 © Springer Nature Switzerland AG 2019 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Switzerland AG The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland

Preface

Non-psychotic mental disorders are amongst the most common morbidities in pregnancy and postpartum (together referring to the perinatal period). So far, research about mental disorders in the perinatal period has largely focused on depression, particularly postpartum depression, even though increasing evidence shows a substantial morbidity with other psychiatric disorders such as anxiety disorders, obsessive-­compulsive disorders, eating disorders, bipolar and schizophrenia spectrum disorders. Furthermore, recently available evidence from literature underlines the importance to consider both antepartum and postpartum period as equally particularly vulnerable and risky for pregnant and nursing women’s mental health. In the last decade, there have been a growing number of evidence-based publications in the field of perinatal psychiatry, some focusing on the risk of an untreated psychiatric disorder for the mother and foetus or infant, others on the efficacy and safety of the available treatments, including psychotropic drugs. Individualised risk/ benefit analyses are needed when judging the use of a drug treatment in the perinatal p